In the evolving field of biochemical rese Gadolinium-diethylenetriamine pentaacetic acid - NCBI - NIH arch and molecular imaging, the development of specialized probes has become a cornerstone for laboratory investigations. Among these, the dtpa peptide conjugate stands out as a sophisticated tool for researchers looking to bridge the gap between metal chelation and biological targeting. As someone deeply involved in the synthesis and application of these molecular structures, I have found that the precision offered by these conjugates is unparalleled in controlled experimental enviro by AD Quinn · 1994 · Cited by 96 — Gd-DTPA can be used to provide enhancement during CT and might be of value in iodine-sensitive patients. nments.
The Chemistry Behind the DTPA Peptide Framework
At its core, DTPA This product-line includes standard MRI contrast agents, such as Gd-DTPA. BioPAL's Gado-DTPA™ is gadolinium-DTPA bottled at a concentration of 469 mg/ml (diethylenetriaminepentaacetic acid) is an aminopolycarboxylic acid consisting of a diethylenetriamine backbone with five carboxymethyl groups. This structure makes it an exceptional chelating agent. When we discuss gadolinium-DTPA, we are referring to the complexation of the rare-earth element gadolinium with this backbone, resulting in a stable, paramagnetic structure.
In scientific literature, gd-dtpa gadolinium diethylenetriaminepentaacetate is frequently cited for its role in forming the foundation of many diagnostic probes. However, when researchers want to target specific biological markers, they synthesize a peptide-based conjugate. By attaching a targeting sequence to the DTPA, we create a probe that can deliver the chelator to specific sites of interest with high affinity.
Applications in Experimental Imaging
The versatility of this technology is highlighted by various derivatives:
* Gd-DTPA-VGB3: This novel agent has been developed to target vascular endothelial growth factor receptor-1 (VEGFR1). It serves as a prime example of how targeted delivery improves the re Find gd-dtpa gadolinium diethylenetriaminepentaacetate and related products for scientific research at MilliporeSigma. solution of imaging in tumor models.
* Gd-C4-thyroxin-DTPA: This specific construct is designed to interact strongly with human serum albumin (HSA), demonstrating the potential for long-circulating probes.
* Gd-DTPA labeled albumin: This is an intravascular MRI contrast agent that utilizes the covalent bonding of multiple chelates per protein molecule to provide enhanced signal stability.
For those curious about the physical properties of these materials, gadolinium-DTPA bottled at a concentration of 469 mg/ml is a standard laboratory reference point. It is also fascinating to note that Gd-DTPA can be us Gd-dtpa gadolinium diethylenetriaminepentaacetate ed to provide enhancement during CT scans, illustrating that its utility extends beyond traditional magnetic resonance imaging.
Technical Considerations and Safety Protocols
When working with these substances in a research setting, it is critical to understand the material's nature. Gd DTPA is a gadolinium-based contrast agent that alters the magnetic properties of water molecules in its vicinity.
It is important to distinguish between various forms of these salts. For instance, Ca-DTPA and Zn-DTPA can be administered by nebulizer or directly into the blood stream in specific detoxification research models. Conversely, Gd-labeled diethylenetriaminepentaacetic acid (Gd-DTPA) is strictly utilized for its imaging properties. In the clinica Pentetic acid: Uses, Interactions, Mechanism of Action | DrugBank l history of these compounds, Gd-DTPA-dimeglumine was one of the first formulations to undergo rigorous safety and efficacy evaluations.
The Future of Targeted Probes
The synthesis of diethylenetriaminepentaacetic acid gadolinium (DTPA-Gd) derivatives, such as those conjugated with polymers like polyethylene glycol, continues to push the boundaries of what these molecules can achieve. Whether it is Gd-Diethylenetriaminepentaacetate (Gd-DTPA) or the more complex Gd-C(4)-thyroxin-DTPA, the goal remains the same: to create a substance used in magnetic resonance imaging (MRI) that provides higher specificity and reduced background interference.
As a synthetic polyamino carboxylic acid, DTPA remains the gold standard for chelation chemistry. Its ability to form a Gadolinium-DTPA as a contrast agent in MRI: initial clinical stable complex under physiological conditions—ensuring the metal ion remains sequestered—is why it remains a primary focus in t Diethylenetriaminepentaacetic acid-gadolinium (DTPA-Gd) he development of the next generation of targeted molecular probes. For any researcher, mastering the conjugation of these peptides is an essential step in advancing the precision of modern molecular imaging studies.